K292-1207 Screening compound: methyl 2-{2-[(4-oxo-3-{5-[(2-phenylethyl)carbamoyl]pentyl}-3H,4H-thieno[3,2-d]pyrimidin-2-yl)sulfanyl]acetamido}benzoate

K292-1207 Screening compound: methyl 2-{2-[(4-oxo-3-{5-[(2-phenylethyl)carbamoyl]pentyl}-3H,4H-thieno[3,2-d]pyrimidin-2-yl)sulfanyl]acetamido}benzoate
K292-1207 Screening compound: methyl 2-{2-[(4-oxo-3-{5-[(2-phenylethyl)carbamoyl]pentyl}-3H,4H-thieno[3,2-d]pyrimidin-2-yl)sulfanyl]acetamido}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound K292-1207
methyl 2-{2-[(4-oxo-3-{5-[(2-phenylethyl)carbamoyl]pentyl}-3H,4H-thieno[3,2-d]pyrimidin-2-yl)sulfanyl]acetamido}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K292-1207

Molecular Formula

C30H32N4O5S2 (C30 H32 N4 O5 S2)

Compound Name

methyl 2-{2-[(4-oxo-3-{5-[(2-phenylethyl)carbamoyl]pentyl}-3H,4H-thieno[3,2-d]pyrimidin-2-yl)sulfanyl]acetamido}benzoate

IUPAC name

methyl 2-{2-[(4-oxo-3-{5-[(2-phenylethyl)carbamoyl]pentyl}-3H4H-thieno[32-d]pyrimidin-2-yl)sulfanyl]acetamido}benzoate

SMILES

COC(c(cccc1)c1NC(CSC(N(CCCCCC(NCCc1ccccc1)=O)C1=O)=Nc2c1scc2)=O)=O

InChI

InChI=1S/C30H32N4O5S2/c1-39-29(38)22-12-7-8-13-23(22)32-26(36)20-41-30-33-24-16-19-40-27(24)28(37)34(30)18-9-3-6-14-25(35)31-17-15-21-10-4-2-5-11-21/h2,4-5,7-8,10-13,16,19H,3,6,9,14-15,17-18,20H2,1H3,(H,31,35)(H,32,36)

InChI Key

OKZSPMGPNABJCH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15091705

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

592.74

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

17.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.786

Distribution Coefficient, logD

3.777

Water Solubility, LogSw

-3.89

Polar Surface Area

94.706

Acid Dissociation Constant (pKa)

9.11

Base Dissociation Constant (pKb)

-0.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

K292-1207 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with K292-1207 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K292-1207?
Check Price and Availability of K292-1207, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K292-1207 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K292-1207
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K292-1207
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K292-1207 available by request